-
My Account
My Account
BSE Live
Apr 20, 16:00Prev. Close
542.00
Open Price
540.00
Bid Price (Qty.)
548.25 (3)
Offer Price (Qty.)
548.25 (100)
NSE Live
Apr 20, 15:50Prev. Close
541.10
Open Price
545.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
548.40 (8)
| Half Yearly Results of Kansai Nerolac Paints (in Rs. Cr.) | Sep '20 | Mar '20 | Sep '19 | Mar '19 | Mar '18 | |
| Net Sales/Income from operations | 1,868.46 | 2,221.40 | 2,706.99 | 2,485.62 | 2,237.54 | |
| Other Operating Income | 17.68 | 14.78 | -- | 18.20 | 11.03 | |
| Total Income From Operations | 1,886.14 | 2,236.18 | 2,706.99 | 2,503.82 | 2,248.57 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 966.78 | 1,256.13 | 1,466.05 | 1,614.40 | 1,374.01 | |
| Purchase of Traded Goods | 130.96 | 152.24 | 131.99 | 138.87 | 113.01 | |
| Increase/Decrease in Stocks | 33.76 | -20.50 | 71.71 | -134.18 | -116.29 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 128.47 | 132.47 | 136.91 | 128.62 | 114.95 | |
| Depreciation | 64.86 | 63.46 | 56.42 | 46.99 | 39.04 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 286.28 | 396.17 | 438.38 | 429.51 | 401.72 | |
| P/L Before Other | 275.03 | 256.21 | 405.53 | 279.61 | 322.13 | |
| Other Income | 12.27 | 16.41 | 10.45 | 34.29 | 38.39 | |
| P/L Before Int. | 287.30 | 272.62 | 415.98 | 313.90 | 360.52 | |
| Interest | 2.43 | 2.50 | 2.50 | -- | -- | |
| P/L Before Exceptional Items & Tax | 284.87 | 270.12 | 413.48 | 313.90 | 360.52 | |
| Exceptional Items | -10.82 | -- | -- | -- | -- | |
| P/L Before Tax | 274.05 | 270.12 | 413.48 | 313.90 | 360.52 | |
| Tax | 72.79 | 76.01 | 72.19 | 108.38 | 129.56 | |
| P/L After Tax from Ordinary Activities | 201.26 | 194.11 | 341.29 | 205.52 | 230.96 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 201.26 | 194.11 | 341.29 | 205.52 | 230.96 | |
| Equity Share Capital | 53.89 | 53.89 | 53.89 | 53.89 | 53.89 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 3.73 | 3.60 | 6.33 | -- | -- | |
| Diluted EPS | 3.73 | -- | 6.33 | -- | -- | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 3.73 | 3.60 | 6.33 | -- | -- | |
| Diluted EPS. | 3.73 | -- | 6.33 | -- | -- | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
01.02.2021
Kansai Nerolac Consolidated December 2020 Net Sales at Rs 1,592.55 crore, up 19.57% Y-o-Y
01.02.2021
Kansai Nerolac Standalone December 2020 Net Sales at Rs 1,473.38 crore, up 18.05% Y-o-Y
04.11.2020
Kansai Nerolac Standalone September 2020 Net Sales at Rs 1,288.09 crore, up 3.58% Y-o-Y
04.11.2020
Kansai Nerolac Consolidated September 2020 Net Sales at Rs 1,383.21 crore, up 4.35% Y-o-Y
10.04.2021
Kansai Nerolac Q4 PAT seen up 89.6% YoY to Rs 135.4 cr: ICICI Direct
18.01.2021
Kansai Nerolac Q3 PAT seen up 39.8% YoY to Rs. 171.6 cr: ICICI Direct
10.10.2019
Kansai Nerolac Q2 PAT seen up 15.1% YoY to Rs. 140.5 cr: ICICI Direct
11.07.2019
Kansai Nerolac Q1 PAT may dip 10.8% YoY to Rs. 123.7 cr: ICICI Direct
